Zobrazeno 1 - 10
of 195
pro vyhledávání: '"Yoshihide, Kawasaki"'
Autor:
Tetsuro Shiraiwa, Hiromichi Katayama, Yudai Iwasaki, Shingo Kimura, Yohei Satake, Takuma Sato, Yoshihide Kawasaki, Naoki Kawamorita, Shinichi Yamashita, Akihiro Ito
Publikováno v:
IJU Case Reports, Vol 7, Iss 4, Pp 285-288 (2024)
Introduction Choriocarcinoma syndrome with multiple lung metastases has a poor prognosis and causes respiratory failure due to alveolar hemorrhage. We encountered a case where the introduction of extracorporeal membrane oxygenation effectively sustai
Externí odkaz:
https://doaj.org/article/dfce6a2e52ae4299831b1a2c5e3bc155
Autor:
Yasufumi Sato, Yoshihide Kawasaki, Yohei Satake, Yoshiteru Shimoda, Hiromichi Katayama, Takuma Sato, Shuichi Shimada, Naoki Kawamorita, Shinichi Yamashita, Masayuki Kanamori, Akihiro Ito
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 1573-1578 (2023)
Although the response to combination therapy has been reported in patients with brain metastases from advanced renal cancer, treatment-related cerebral hemorrhage has not been adequately studied. The CheckMate 9ER clinical trial of nivolumab and cabo
Externí odkaz:
https://doaj.org/article/d5007c5432924eee942c6ed430289b2c
Autor:
Tomoyuki Koguchi, Sei Naito, Shingo Hatakeyama, Kazuyuki Numakura, Yumina Muto, Renpei Kato, Takahiro Kojima, Yoshihide Kawasaki, Kento Morozumi, Shuya Kandori, Sadafumi Kawamura, Hiroyuki Nishiyama, Akihiro Ito, Tomonori Habuchi, Wataru Obara, Chikara Ohyama, Norihiko Tsuchiya, Yoshiyuki Kojima
Publikováno v:
Cancer Medicine, Vol 12, Iss 22, Pp 20677-20689 (2023)
Abstract Objectives To investigate the efficacy of pharmacotherapy for metastatic non‐clear cell renal cell carcinoma (nccRCC) in Japanese population. Methods In this retrospective analysis, we compared the time to treatment failure (TTF) for molec
Externí odkaz:
https://doaj.org/article/5e7b3e75be6e417381a401e25356929a
Autor:
Tomokazu Sazuka, Yuto Matsushita, Hiroaki Sato, Takahiro Osawa, Nobuyuki Hinata, Shingo Hatakeyama, Kazuyuki Numakura, Kosuke Ueda, Takahiro Kimura, Masayuki Takahashi, Hajime Tanaka, Yoshihide Kawasaki, Toshifumi Kurahashi, Takuma Kato, Kazutoshi Fujita, Makito Miyake, Takahiro Kojima, Hiroshi Kitamura, Hideaki Miyake, Tomohiko Ichikawa
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Immuno-oncology (IO) combination therapy is utilized as a first-line systemic treatment for advanced renal cell carcinoma. However, evidence supporting the use of cabozantinib after IO combination therapy is lacking. We retrospectively analy
Externí odkaz:
https://doaj.org/article/3dd95354eaea4996aad3f064f3d0cd29
Autor:
Maiko Yamashita, Takanari Sakai, Shinichi Yamashita, Fumiyoshi Fujishima, Takuro Goto, Takuma Sato, Yoshihide Kawasaki, Naoki Kawamorita, Takaki Tanaka, Akihiro Ito
Publikováno v:
IJU Case Reports, Vol 6, Iss 4, Pp 226-229 (2023)
Introduction In testicular cancer, late relapse of teratoma with somatic‐type malignancy is rare and associated with a poor survival. A case of retroperitoneal lymph node metastasis of teratoma with somatic‐type malignancy 18 years after initial
Externí odkaz:
https://doaj.org/article/e76f5c7504c24004bc62fca83c46da7e
Autor:
Ryuta Sobu, Kazuyuki Numakura, Sei Naito, Shingo Hatakeyama, Renpei Kato, Tomoyuki Koguchi, Takahiro Kojima, Yoshihide Kawasaki, Syuya Kandori, Sadafumi Kawamura, Yoichi Arai, Akihiro Ito, Hiroyuki Nishiyama, Yoshiyuki Kojima, Wataru Obara, Chikara Ohyama, Norihiko Tsuchiya, Tomonori Habuchi
Publikováno v:
Cancer Medicine, Vol 12, Iss 4, Pp 4100-4109 (2023)
Abstract It remains unknown whether the early response to vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR‐TKI) management in malignancies links to long‐term survival. The objective of this study was to investigate the
Externí odkaz:
https://doaj.org/article/24099fdcb8384362b97b3056f59518f8
Autor:
Masamitsu Maekawa, Tomonori Sato, Chika Kanno, Izumi Sakamoto, Yoshihide Kawasaki, Akihiro Ito, Nariyasu Mano
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 7, p 4098 (2024)
Glycosphingolipids (GSLs), mainly located in the cell membrane, play various roles in cancer cell function. GSLs have potential as renal cell carcinoma (RCC) biomarkers; however, their analysis in body fluids is challenging because of the complexity
Externí odkaz:
https://doaj.org/article/15e1148a161a4cf4818fa4e2307e660a
Autor:
Kento Morozumi, Yoshihide Kawasaki, Tomonori Sato, Masamitsu Maekawa, Shinya Takasaki, Shuichi Shimada, Takanari Sakai, Shinichi Yamashita, Nariyasu Mano, Akihiro Ito
Publikováno v:
Metabolites, Vol 14, Iss 3, p 170 (2024)
Tyrosine kinase inhibitors (TKIs) play a crucial role in the treatment of advanced renal cell carcinoma (RCC). However, there is a lack of useful biomarkers for assessing treatment efficacy. Through urinary metabolite analysis, we identified the meta
Externí odkaz:
https://doaj.org/article/d60a018b8766448785e64fb45053e49c
Autor:
Kazuya Takeda, Yoshihide Kawasaki, Toru Sakayauchi, Chiaki Takahashi, Yu Katagiri, Takaya Tanabe, Yojiro Ishikawa, Keisuke Fujimoto, Masaki Kubozono, Maiko Kozumi, Keiko Abe, Kakutaro Narazaki, Shun Tasaka, Rei Umezawa, Takaya Yamamoto, Noriyoshi Takahashi, Yu Suzuki, Keita Kishida, So Omata, Akihiro Ito, Keiichi Jingu
Publikováno v:
Asia Oceania Journal of Nuclear Medicine and Biology, Vol 11, Iss 1, Pp 13-22 (2023)
Objective(s): In the treatment of castration-resistant prostate cancer (CRPC) with bone metastases, radium-223 dichloride (Ra-223) is the only bone-targeted drug that shows survival benefits. Completing six courses of Ra-223 treatment is thought to b
Externí odkaz:
https://doaj.org/article/7d86a3f742524bdcb3e14f6fe508f826
Autor:
Takuya Nakagawa, Yoshihide Kawasaki, Satoko Sato, Hiromichi Katayama, Yohei Satake, Shuichi Shimada, Takuma Sato, Naoki Kawamorita, Shinichi Yamashita, Koji Mitsuzuka, Atsushi Kohyama, Masaharu Ishida, Hideo Ohtsuka, Michiaki Unno, Akihiro Ito
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 3, Pp 1014-1020 (2022)
In a rare case, free from systemic therapy, deferred cytoreductive nephrectomy was implemented in treating an advanced renal cell carcinoma with liver, lung, and splenic colon metastases. A 59-year-old man diagnosed with advanced renal cell carcinoma
Externí odkaz:
https://doaj.org/article/df422bb597a74405a353f680d9e93c1f